Clinical Review Clinical evidence Glycaemic control in diabetes BMJ 1999; 319 doi: https://doi.org/10.1136/bmj.319.7202.104 (Published 10 July 1999) Cite this as: BMJ 1999;319:104 Article Related content Metrics Responses Peer review Related articles Letter UK's diagnostic criteria for diabetes are different from US's Published: 02 October 1999; BMJ 319 doi:10.1136/bmj.319.7214.922 See more Type 1 diabetes: Randox removes adverts after claims that it was using fear to sell genetic test BMJ March 25, 2024, 384 q744; DOI: https://doi.org/10.1136/bmj.q744 FDA approves first over-the-counter blood glucose monitor for diabetes BMJ March 11, 2024, 384 q611; DOI: https://doi.org/10.1136/bmj.q611 US food manufacturer can say that eating yogurt reduces risk of type 2 diabetes, says FDA BMJ March 06, 2024, 384 q569; DOI: https://doi.org/10.1136/bmj.q569 Scarlett McNally: Preventing obesity is different from curing it—and even more urgent BMJ January 23, 2024, 384 q134; DOI: https://doi.org/10.1136/bmj.q134 Artificial pancreases for type 1 diabetes: Better access is “watershed moment”—but delivery is key BMJ January 23, 2024, 384 q102; DOI: https://doi.org/10.1136/bmj.q102 Cited by... Effect of the p75 Neurotrophin Receptor on Glycemic Control of Obese Mice during Time-Restricted FeedingAbstract Fulltext PDF Continuous Subcutaneous Insulin Infusion at 25 Years: Evidence base for the expanding use of insulin pump therapy in type 1 diabetesAbstract Fulltext PDF UK's diagnostic criteria for diabetes are different from US'sAbstract Fulltext PDF
